A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact

Elliot Marseille and James G Kahn

PLOS Medicine, 2016, vol. 13, issue 5, 1-3

Abstract: In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002031 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 02031&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1002031

DOI: 10.1371/journal.pmed.1002031

Access Statistics for this article

More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().